Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ccm.2014.11.002 http://scihub22266oqcxt.onion/10.1016/j.ccm.2014.11.002 C4710582!4710582!25676522     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Chest+Med 2015 ; 36 (1): 91-9 Nephropedia Template TP {{tp|p=25676522|t=2015. Nontuberculous Mycobacteria Infections in Immunosuppressed Hosts |pdf=|usr=}}{{25676522}} gab.com Text Nontuberculous Mycobacteria Infections in Immunosuppressed Hosts JO: Clin Chest Med http://www.kidney.de/pget.php?&tw=1&pmid=25676522 #FOAvip Diseases and therapies that reduce cell-mediated immunity increase the risk of nontuberculous mycobacterial (NTM) disease. Historically acquired immunodeficiency virus (AIDS), cancer, and hematologic and solid organ transplants have been associated with NTM disease. More recently, immunosuppressive drugs including anti-tumor necrosis factor (anti-TNF) biologics have been associated with NTM disease in population-based studies. Extrapulmonary NTM disease, including disseminated and skin and catheter-related disease, is more common in immunosuppressed compared to immunocompetent patients. Mycobacterium avium complex remains the most common cause of NTM infection of all sites, but rapid growers including M. abscessus, M. chelonae, and M. fortuitum play an important role in skin and catheter-related infections. With the exception of prophylaxis for AIDS patients with very low CD4+ counts, the prevention of NTM remains difficult. Management is complicated and involves restoring immune function and removing catheters in addition to treatment with species-specific antibiotic treatment per current ATS/IDSA guidelines. Twit Text FOAVip Nontuberculous Mycobacteria Infections in Immunosuppressed Hosts ????Clin Chest Med http://www.kidney.de/pget.php?&tw=1&pmid=25676522 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25676522 #FOAvip English Wikipedia <ref>{{Cite pmid|25676522}}</ref> Nontuberculous Mycobacteria Infections in Immunosuppressed Hosts #MMPMID25676522 Henkle E; Winthrop K Clin Chest Med 2015[Mar]; 36 (1): 91-9 PMID25676522show ga Diseases and therapies that reduce cell-mediated immunity increase the risk of nontuberculous mycobacterial (NTM) disease. Historically acquired immunodeficiency virus (AIDS), cancer, and hematologic and solid organ transplants have been associated with NTM disease. More recently, immunosuppressive drugs including anti-tumor necrosis factor (anti-TNF) biologics have been associated with NTM disease in population-based studies. Extrapulmonary NTM disease, including disseminated and skin and catheter-related disease, is more common in immunosuppressed compared to immunocompetent patients. Mycobacterium avium complex remains the most common cause of NTM infection of all sites, but rapid growers including M. abscessus, M. chelonae, and M. fortuitum play an important role in skin and catheter-related infections. With the exception of prophylaxis for AIDS patients with very low CD4+ counts, the prevention of NTM remains difficult. Management is complicated and involves restoring immune function and removing catheters in addition to treatment with species-specific antibiotic treatment per current ATS/IDSA guidelines. äNontuberculous Mycobacteria Infections in Immunosuppressed Hosts (epmc).pdf DeepDyve Pubget Overpricing